Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry
ConditionAortic Valve Stenosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Luebeck
About this trial
Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).
Eligibility criteria
Qualifiers
Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement
BMI <35 kg/m2
Ability to give informed consent
Disqualifiers
History of coronary artery bypass graft and a patent left internal mammary artery (LIMA)
Age ≤18 years
Patients presenting with pregnancy
Patients without informed consent
Trial design
Treatments tested in this trial
- transaxillary (TAX) transcatheter aortic valve replacement
Treatment groups
No treatment groups listed
Sponsors and collaborators
University of Luebeck
Lead sponsor
University Hopsital Schleswig Holstein Campus Lübeck
Collaborator
Source ClinicalTrials.gov